Holen Sie sich die Stockscreener-App
1.99
5.29%
0.10
Vorhandelsmarkt:
2.01
0.02
+1.01%
Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten
Order flow analysis tools used on Citius Oncology Inc.Analyst Upgrade & Low Drawdown Trading Strategies - Newser
How to monitor Citius Oncology Inc. with trend dashboards2025 Earnings Surprises & Proven Capital Preservation Methods - Newser
Analyzing net buyer seller activity in Citius Oncology Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser
What machine learning models say about Citius Oncology Inc.Weekly Trading Summary & Real-Time Volume Analysis - Newser
Is this a good reentry point in Citius Oncology Inc.July 2025 Volume & High Accuracy Swing Entry Alerts - Newser
What moving averages say about Citius Oncology Inc.Risk Management & Long Hold Capital Preservation Tips - Newser
Can momentum traders help lift Citius Oncology Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
What earnings revisions data tells us about Citius Oncology Inc.Market Performance Recap & Smart Swing Trading Alerts - Newser
Can a trend reversal in Citius Oncology Inc. lead to recoveryJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Published on: 2025-08-25 20:41:11 - Newser
Citius Oncology shares rise 2.86% intraday after deploying AI platform to support LYMPHIR launch. - AInvest
Is Citius Oncology Inc. stock trending bullishWeekly Market Outlook & Low Risk High Reward Trade Ideas - theviewers.co.kr
Is Citius Oncology Inc. vulnerable to short sellersWeekly Trade Analysis & Long Hold Capital Preservation Tips - theviewers.co.kr
Volume spikes in Citius Oncology Inc. stock – what they meanQuarterly Market Review & Accurate Buy Signal Notifications - Newser
Automated trading signals detected on Citius Oncology Inc.Quarterly Portfolio Report & Growth Focused Entry Reports - Newser
Citius Oncology Inc. stock chart pattern explained2025 Price Momentum & Short-Term Swing Trade Alerts - Newser
Citius Oncology Inc. stock retracement – recovery analysisNew Guidance & Free Safe Entry Trade Signal Reports - Newser
Can trapped investors hope for a rebound in Citius Oncology Inc.2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Citius Oncology Inc. Rebounds From Oversold Zone — Now What2025 Technical Patterns & Free Verified High Yield Trade Plans - newsyoung.net
Is Citius Oncology Inc. forming bullish engulfing patternsJuly 2025 Review & Expert Curated Trade Setups - kpenews.com
Identifying reversal signals in Citius Oncology Inc.Forecast Cut & Fast Entry High Yield Tips - Newser
Evaluating Citius Oncology Inc. with trendline analysis2025 Momentum Check & High Accuracy Investment Signals - Newser
Why is Citius Oncology Inc. stock going downEarnings Trend Report & Fast Exit/Entry Strategy Plans - sundaytimes.kr
Can swing trading help recover from Citius Oncology Inc. lossesPortfolio Gains Summary & Daily Chart Pattern Signals - Newser
Setup Watch: Is Citius Oncology Inc. exposed to currency risksQuarterly Trade Summary & Reliable Price Breakout Signals - sundaytimes.kr
Exit strategy if you’re trapped in Citius Oncology Inc.Quarterly Market Summary & Risk Controlled Stock Pick Alerts - Newser
The Oncology Institute, Inc. shares rise 1.58% after-hours following Citius Oncology's AI platform deployment for LYMPHIR™ therapy. - AInvest
Citius Pharmaceuticals shares rise 7.32% intraday after Citius Oncology deployed an AI platform for targeted sales and marketing strategies. - AInvest
Citius Oncology Inc. Breaks Losing Streak — Is the Trend ReversingBear Alert & Capital Efficiency Focused Ideas - beatles.ru
Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch - MarketScreener
Citius Oncology deploys AI platform to support LYMPHIR launch By Investing.com - Investing.com South Africa
Citius Oncology deploys AI platform to support LYMPHIR launch - Investing.com
Citius Oncology Deploys AI Platform to Amplify the Performance of Its Commercial Team Ahead of LYMPHIR Launch - 富途牛牛
AI-Driven Precision: How Citius Oncology is Reshaping Oncology Commercialization with LYMPHIR in CTCL - AInvest
Citius Oncology Deploys AI Platform to Amplify Commercial Team Ahead of LYMPHIR Launch - AInvest
Earnings Miss: Is Citius Oncology Inc. stock good for income investors2025 Technical Patterns & Daily Growth Stock Tips - theviewers.co.kr
Citius Oncology Inc. stock trend outlook and recovery path2025 AllTime Highs & Low Drawdown Investment Ideas - Newser
Citius Oncology Inc. Sees Relief Buying After Extended DropPortfolio Gains Report & Precise Buy Zone Identification - beatles.ru
Citius Oncology Conducts Public Offering of Stock - MSN
Citius Oncology Announces Closing of $9.0 Million Public Offering - ADVFN Brasil
Analyzing Citius Oncology Inc. with risk reward ratio charts2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
Citius Oncology files prospectus supplement to update S-1 registration By Investing.com - Investing.com Australia
Citius Oncology files prospectus supplement to update S-1 registration - Investing.com
RSI Suggests Rebound May Be Near in Citius Oncology Inc.M&A Rumor & AI Driven Stock Movement Reports - classian.co.kr
Trading Bots Trigger Alerts on Citius Oncology Inc. ActivityGold Moves & Daily Momentum Trading Reports - classian.co.kr
Citius Oncology Inc. Added to High Probability Setup ListWall Street Watch & Free Real-Time Volume Trigger Notifications - newsimpact.co.kr
Will Citius Oncology Inc. Benefit From Broader Market BounceJuly 2025 Review & Entry and Exit Point Strategies - classian.co.kr
How hedge fund analytics apply to Citius Oncology Inc. stockJuly 2025 Reactions & Breakout Confirmation Trade Signals - Newser
Risk adjusted return profile for Citius Oncology Inc. analyzedDay Trade & Capital Protection Trade Alerts - Newser
Published on: 2025-08-17 14:00:03 - mustnews.co.kr
Citius Oncology Inc. stock momentum explainedJuly 2025 Review & Reliable Momentum Entry Alerts - Newser
Is Citius Oncology Inc. exposed to currency risks2025 Volume Leaders & Reliable Momentum Entry Alerts - sundaytimes.kr
Is Citius Oncology Inc. showing insider buyingWeekly Investment Summary & Fast Entry Momentum Trade Alerts - thegnnews.com
Is Citius Oncology Inc. meeting your algorithmic filter criteriaWeekly Trading Summary & Daily Growth Stock Investment Tips - Newser
Citius Pharmaceuticals shares fall 3.85% intraday after reporting fiscal third quarter results and raising $12.5 million in financings. - AInvest
Citius Oncology Beats Fiscal Q3 EPS - AOL.com
0.07%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):